An interventional study of Parent Smart Holistic Health Care Platform (P-SHHCP) and Child Smart Holistic Health Care Platform (C-SHHCP) in Leukemia (Both ALL and AML) and Brain Tumors, sponsored by National Defense Medical University, Taiwan. Recruiting at 1 site in Taiwan. Open to participants aged 7 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-04.
Sponsored by National Defense Medical University, Taiwan · Not applicable, Interventional, and Supportive care
Among 26 studies in Leukemia with a site in Taiwan — 4 open to participants now, 9 under way, 4 of them phase 3. Leukemia · Taiwan.
Among the 26 studies in Leukemia with a site in Taiwan, this one is the 18th largest by planned enrollment of the 23 interventional ones, is one of 2 that started in 2025, is the only one with no phase, and was the 26th registered.
2,381 studies on the registry are indexed under Leukemia; 253 are open to participants now.
This study's planned enrollment of 120 is above the median of 40 across 1,769 interventional studies indexed under Leukemia.
Browse Leukemia studies →4 of the 26 studies in Leukemia with a site in Taiwan are open now, in 12 countries. Each count lists the studies.
Of the 208 Leukemia studies recruiting now, 112 (54%) set no upper age limit and 74 (36%) stop at 75 or younger; 86 take children under 18; 24 take healthy volunteers.
This study: 7 Years and older · all sexes · healthy volunteers too.
The full table on the hub →26 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 2 started in 2025.
Median enrollment 307 across the 23 interventional studies, 1,456 across the 3 observational. Of the 15 that completed or were terminated, 13 (87%) have results posted.
21 of 26 have an industry lead sponsor. The 10 most frequent:
National Defense Medical University, Taiwan is the lead sponsor of 3 studies on the registry; 3 are open to participants now.
National Defense Medical University, Taiwan has 1 study filed under Leukemia — fewer than ten, so there is no comparison to draw.
2 of the studies in Leukemia with a site in Taiwan that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03836261Phase 3Acerta Pharma BVStudy of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL | 2027-04-30 |
| NCT05475925Dren BioA Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas | 2026-12 |
Among the 26 studies in Leukemia with a site in Taiwan, from their registry updates:
This multicenter randomized controlled trial aims to develop and evaluate two Smart Holistic Health Care Platforms (SHHCPs) for families of children with cancer in Taiwan: the Parent Smart Holistic Health Care Platform (P-SHHCP) for parents and the Child Smart Holistic Health Care Platform (C-SHHCP) for children. Children diagnosed with leukemia or brain tumors and their primary caregivers (parents) will be recruited from pediatric oncology and hematology units at four medical centers in northern Taiwan. The SHHCPs are designed to strengthen communication and connection between families and health care providers and to provide holistic support for physical, psychological, social, and spiritual needs during cancer treatment.The study will evaluate the effects of the P-SHHCP and C-SHHCP on the physical, psychological, social, and spiritual well-being of children with cancer and their parents during treatment.
This study is a multicenter randomized controlled trial conducted at four medical centers in northern Taiwan: Tri-Service General Hospital, National Taiwan University Hospital, Taipei Veterans General Hospital, and Mackay Memorial Hospital. Children diagnosed with leukemia or brain tumors and their primary caregivers (parents) will be recruited from pediatric oncology and hematology units using convenience sampling.
The study aims to develop and evaluate two Smart Holistic Health Care Platforms (SHHCPs): the Parent Smart Holistic Health Care Platform (P-SHHCP) and the Child Smart Holistic Health Care Platform (C-SHHCP). The platforms are designed to strengthen communication between families and health care providers and to provide holistic support addressing physical, psychological, social, and spiritual needs throughout cancer treatment.
Eligible parent and child participants will complete baseline assessments before the intervention. Participants assigned to the intervention group will receive the SHHCP intervention, while participants assigned to the control group will receive usual care. Outcome measures will be assessed at four time points: baseline (T0), 2 months (T1), 5 months (T2), and 8 months (T3).
For parents, the study will evaluate fatigue, quality of life, anxiety, resilience, post-traumatic growth, parenting self-efficacy, and spiritual well-being. For children, outcomes will include cancer-related fatigue, pediatric quality of life, physical and psychological health, behavioral and emotional outcomes, and spiritual well-being. The primary objective is to determine whether the P-SHHCP and C-SHHCP improve the physical, psychological, social, and spiritual health and well-being of parents and children during cancer treatment compared with usual care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Parents:
Parent of a child diagnosed with leukemia or a brain tumor. The child is between 2 and 18 years of age. The parent is the primary caregiver of the child, agrees to participate in the study, and is willing to complete self-administered questionnaires.
Able to speak, understand, read, and write Chinese. Has access to the Internet. Has no cognitive impairment. Has not previously participated in another study involving a smart health care platform.
Is not taking medications that may affect fatigue, anxiety, mood, or behavior.
Children:
Diagnosed with leukemia or a brain tumor. Between 7 and 18 years of age. Is not taking medications that may affect fatigue, anxiety, mood, or behavior. Able to communicate in Chinese. Has no cognitive impairment. Able to use a smartphone or tablet independently or with assistance from a caregiver.
Will not participate in another smart health care platform study during the study period.
Has a stable disease condition and emotional status.
Exclusion Criteria:
Parents:
The child has not been diagnosed with leukemia or a brain tumor. The parent is not the primary caregiver of the child or is unwilling to participate in the study and complete the study questionnaires.
Unable to speak, understand, read, or write Chinese. Does not have access to the Internet. Has cognitive impairment. Has previously participated in another study involving a smart health care platform.
Is taking medications that may affect fatigue, anxiety, mood, or behavior.
Children:
Has a psychiatric disorder, such as schizophrenia, depression, or bipolar disorder, or has cognitive impairment or a sleep disorder.
Has a congenital disease or congenital anomaly. Has a severe medical condition requiring treatment, such as a severe infection. Has terminal-stage cancer with multiple complications.
Participants in the intervention group will receive the Smart Holistic Health Care Platform (SHHCP) in addition to usual care. Parents will receive the Parent Smart Holistic Health Care Platform (P-SHHCP), and children will receive the Child Smart Holistic Health Care Platform (C-SHHCP). The platforms are designed to strengthen communication and connection between families and health care providers and to provide physical, psychological, social, and spiritual support during cancer treatment. Outcomes will be assessed at baseline and at 2, 5, and 8 months.
Behavioral: Parent Smart Holistic Health Care Platform (P-SHHCP) · Behavioral: Child Smart Holistic Health Care Platform (C-SHHCP)
Participants in the control group will receive usual care without access to the SHHCP intervention during the study period. They will continue to receive routine clinical care and cancer treatment as provided by their health care team. Outcomes will be assessed at the same time points as the intervention group: baseline and at 2, 5, and 8 months.
The Parent Smart Holistic Health Care Platform (P-SHHCP) is a digital supportive care intervention designed for parents who are the primary caregivers of children with cancer. The platform aims to strengthen communication and connection between parents and health care providers and to provide holistic support addressing physical, psychological, social, and spiritual needs during the child's cancer treatment.
The Child Smart Holistic Health Care Platform (C-SHHCP) is a digital supportive care intervention designed for children with leukemia or brain tumors undergoing cancer treatment. The platform aims to strengthen communication and connection between children, their families, and health care providers and to provide holistic support addressing physical, psychological, social, and spiritual needs during cancer treatment.
Change in Parent Caregiver Fatigue as Measured by the Fatigue Scale-14 (FS-14)
Parent caregiver fatigue will be assessed using the 14-item Fatigue Scale-14 (FS-14). The scale consists of two dimensions: physical fatigue (8 items) and mental fatigue (6 items). Each item is scored as 0 or 1. The total score ranges from 0 to 14, with higher scores indicating greater fatigue.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Child Spiritual Well-Being as Measured by the Feeling Good, Living Life (FGLL) Questionnaire
Child spiritual well-being will be assessed using the Feeling Good, Living Life (FGLL) questionnaire. The instrument assesses children's ideal spiritual well-being ("Feeling Good") and their lived experience of spiritual well-being ("Living Life"). Items are rated on a 5-point scale from 1 (no) to 5 (yes), with higher scores reflecting higher levels of spiritual well-being.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Child Behavioral and Emotional Problems as Measured by the Child Behavior Checklist (CBCL)
Child behavioral and emotional problems will be assessed using the 113-item Child Behavior Checklist (CBCL), a parent-report measure designed for children and adolescents aged 6 to 18 years. Items are rated on a 3-point scale from 0 (absent) to 2 (occurs often), with higher scores indicating greater behavioral and emotional problems.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Parent Caregiver Anxiety as Measured by the Beck Anxiety Inventory (BAI)
Parent caregiver anxiety will be assessed using the 21-item Beck Anxiety Inventory (BAI). Each item is rated on a 4-point scale from 0 to 3. Higher total scores indicate greater severity of anxiety symptoms.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Parent Spiritual Well-Being as Measured by the Spiritual Well-Being Scale (SWBS)
Parent spiritual well-being will be assessed using the 20-item Spiritual Well-Being Scale (SWBS), consisting of religious well-being and existential well-being subscales. Items are rated on a 6-point Likert scale. Total scores range from 20 to 120, with higher scores indicating greater spiritual well-being.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Cancer-Related Fatigue in Children as Measured by the Cancer-Related Fatigue Questionnaire (CRFQ)
Cancer-related fatigue in children will be assessed using the 25-item Cancer-Related Fatigue Questionnaire (CRFQ). The questionnaire assesses four domains: daily activities, general fatigue-related issues, sleep difficulties, and mental and emotional status. Each item is rated on a 4-point scale from 1 to 4. Total scores range from 25 to 100, with lower scores indicating greater cancer-related fatigue.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Parent Caregiver Quality of Life as Measured by the Caregiver Quality of Life Index-Cancer (CQOLC)
Parent caregiver quality of life will be assessed using the 35-item Caregiver Quality of Life Index-Cancer (CQOLC). Items are rated on a 5-point Likert scale from 0 (not at all) to 4 (very much). The scale assesses burden, disruptiveness, positive adaptation, and financial concerns. Total scores range from 0 to 140, with higher scores indicating better quality of life.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Cancer-Related Parenting Self-Efficacy
Cancer-related parenting self-efficacy will be assessed using a 24-item self-report scale designed to evaluate parents' confidence in performing parenting tasks relevant to caring for a child with cancer. Items are rated on a 6-point Likert scale from 1 (strongly disagree) to 6 (strongly agree), with higher scores indicating greater parenting self-efficacy.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Parent Caregiver Posttraumatic Growth as Measured by the Posttraumatic Growth Inventory (PTGI)
Posttraumatic growth will be assessed using the 21-item Posttraumatic Growth Inventory (PTGI). Items are rated on a 6-point scale from 0 to 5. The scale assesses positive changes related to new possibilities, relationships with others, personal strength, spiritual growth, and appreciation of life. Higher scores indicate greater posttraumatic growth.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Pediatric Physical and Psychosocial Health as Measured by the PROMIS Pediatric-25
Pediatric physical and psychosocial health will be assessed using the Patient-Reported Outcomes Measurement Information System Pediatric-25 (PROMIS Pediatric-25). The instrument assesses six domains: physical function, anxiety, depressive symptoms, fatigue, peer relationships, and pain interference. Each domain contains four items rated on a 5-point scale. The instrument also includes a single-item Numeric Pain Rating Scale ranging from 0 (no pain) to 10 (worst imaginable pain).
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Pediatric Health-Related Quality of Life as Measured by the PedsQL 4.0 Generic Core Scales
Pediatric health-related quality of life will be assessed using the 23-item PedsQL 4.0 Generic Core Scales. The scale assesses four domains: physical functioning (8 items), emotional functioning (5 items), social functioning (5 items), and school functioning (5 items). Items are rated on a 5-point response scale from 0 (never a problem) to 4 (almost always a problem). Higher scores indicate better health-related quality of life.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Parent Caregiver Resilience as Measured by the Connor-Davidson Resilience Scale (CD-RISC-25)
Parent caregiver resilience will be assessed using the 25-item Connor-Davidson Resilience Scale (CD-RISC-25). Each item is rated on a 5-point Likert scale from 0 to 4. Total scores range from 0 to 100, with higher scores indicating greater resilience.
Time frame: Baseline, 2 months, 5 months, and 8 months
Change in Cancer-Related Fatigue in Children as Measured by the Cancer-Related Fatigue Questionnaire (CRFQ)
Cancer-related fatigue in children will be assessed using the 25-item Cancer-Related Fatigue Questionnaire (CRFQ). The questionnaire assesses daily activities, general fatigue-related issues, sleep difficulties, and mental and emotional status. Each item is rated on a 4-point scale from 1 to 4. Total scores range from 25 to 100, with lower scores indicating greater fatigue.
Time frame: Baseline, 2 months, 5 months, and 8 months
Started Dec 2025 (actual). Primary completion is estimated for Jul 2028, 31 months after the start.
Of 103 non-industry interventional studies with no phase under Leukemia, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 128. This study's planned 31 months is below that.
Counting every sponsor, half of 110 studies reached it within 38 months; a quarter within 22 and three quarters within 75.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Defense Medical University, Taiwan